Day One Biopharmaceuticals Inc (DAWN) — Financial Flexibility Index
Day One Biopharmaceuticals Inc (DAWN) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-1.99 Million (operating CF $-5.80 Million minus capex $3.82 Million) represents 0% of total liabilities ($62.91 Million). Also explore Day One Biopharmaceuticals Inc (DAWN) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Day One Biopharmaceuticals Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Day One Biopharmaceuticals Inc across 6 annual periods. Check how strategically is Day One Biopharmaceuticals Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Day One Biopharmaceuticals Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Day One Biopharmaceuticals Inc. For the full company profile including market capitalisation, see DAWN market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.95x | $-75.94 Million | $-78.11 Million | $80.04 Million | ▲ +80.5% |
| 2023 | -4.87x | $-143.63 Million | $-146.85 Million | $29.51 Million | ▲ +24.6% |
| 2022 | -6.45x | $-109.85 Million | $-109.87 Million | $17.02 Million | ▼ -38.1% |
| 2021 | -4.67x | $-40.54 Million | $-48.54 Million | $8.67 Million | ▲ +23.2% |
| 2020 | -6.09x | $-13.40 Million | $-13.49 Million | $2.20 Million | ▼ -4378.0% |
| 2019 | -0.14x | $-4.42 Million | $-4.51 Million | $32.52 Million | — |